After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2018/12/181204095344.htm
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2018/12/181204095344.htm
Comments
Post a Comment
Thank you for your message. We are improving our services everyday.